Roberto A. Mignone Joins Guardant Health Board of Directors (Guardant Health)

Guardant Health (Nasdaq: GH) has appointed Roberto A. Mignone, Founder and Managing Partner of Bridger Management, to its board of directors. Mignone brings extensive expertise in healthcare investment and business strategy, enhancing Guardant’s efforts to expand its precision oncology offerings, including its newly FDA-approved colorectal cancer screening product, Shield.

Mignone, who co-founded Blue Ridge Capital and serves as co-Vice Chairman at NYU Langone Medical Center, expressed enthusiasm about contributing to Guardant’s mission to improve global cancer care. Guardant Health’s leadership views his strategic insight as key to driving growth and innovation in the company’s products across the continuum of care.